Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does POLATUZUMAB VEDOTIN Cause Pancytopenia? 126 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Pancytopenia have been filed in association with POLATUZUMAB VEDOTIN (POLIVY). This represents 2.7% of all adverse event reports for POLATUZUMAB VEDOTIN.

126
Reports of Pancytopenia with POLATUZUMAB VEDOTIN
2.7%
of all POLATUZUMAB VEDOTIN reports
45
Deaths
49
Hospitalizations

How Dangerous Is Pancytopenia From POLATUZUMAB VEDOTIN?

Of the 126 reports, 45 (35.7%) resulted in death, 49 (38.9%) required hospitalization, and 5 (4.0%) were considered life-threatening.

Is Pancytopenia Listed in the Official Label?

Yes, Pancytopenia is listed as a known adverse reaction in the official FDA drug label for POLATUZUMAB VEDOTIN.

What Other Side Effects Does POLATUZUMAB VEDOTIN Cause?

Disease progression (1,131) Off label use (692) Anaemia (344) Blood lactate dehydrogenase increased (307) Drug ineffective (305) Neutropenia (303) Death (295) Covid-19 (286) Febrile neutropenia (286) Pyrexia (285)

What Other Drugs Cause Pancytopenia?

METHOTREXATE (5,377) CYCLOPHOSPHAMIDE (3,351) CARBOPLATIN (2,910) RITUXIMAB (2,400) LENALIDOMIDE (2,259) DOXORUBICIN (2,212) VINCRISTINE (2,180) ETOPOSIDE (2,129) DEXAMETHASONE (2,053) PREDNISONE (1,743)

Which POLATUZUMAB VEDOTIN Alternatives Have Lower Pancytopenia Risk?

POLATUZUMAB VEDOTIN vs POLATUZUMAB VEDOTIN-PIIQ POLATUZUMAB VEDOTIN vs POLIDOCANOL POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350 POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM

Related Pages

POLATUZUMAB VEDOTIN Full Profile All Pancytopenia Reports All Drugs Causing Pancytopenia POLATUZUMAB VEDOTIN Demographics